DHODH inhibitor

0 marketed 1 in Phase 3 1 in Phase 2

This page covers all DHODH inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Dihydroorotate dehydrogenase (DHODH), DHODH.

Targets

Dihydroorotate dehydrogenase (DHODH) · DHODH

Phase 3 pipeline (1)

IMU-838 tablets · Immunic AG · Immunology
IMU-838 is a selective immunomodulator that inhibits dihydroorotate dehydrogenase (DHODH) to reduce proliferation of activated lymphocytes while preserving regulatory T cells.

Phase 2 pipeline (1)

DSM265 xmg · Medicines for Malaria Venture · Infectious Diseases
DSM265 is a dihydroorotate dehydrogenase (DHODH) inhibitor.